Online citations, reference lists, and bibliographies.
← Back to Search

Biocatalysis For The Production Of Pharmaceutical Intermediates: Statin Precursors

Anera Švarc, Dino Skendrović, Ana Vrsalović Presečki
Published 2019 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
The application of enzymes in chemical synthesis, due to the recent advances, has a strong impact in multiple industries, especially the pharmaceutical industry. Namely, the use of enzymes shows remarkable advantages over classical chemical catalysis and therefore it is considered a ‘green’ solution. By using novel techniques, it is possible to tailor the enzymes to adapt them for a given process. Today, several pharmaceutical companies are successfully producing valuable precursors for the production of active pharmaceutical ingredients using enzymes, some of them being statin precursors. Statins are hypolipidemics, drugs used for the prevention of cardiovascular diseases and lowering cholesterol concentration in blood. Due to challenges in the chemical synthesis of statin intermediates, the production of statin intermediates using enzyme-catalysed reactions shows some notable advantages. Therefore, research and development laboratories, combined with reaction engineering techniques, have shifted their focus towards applying biochemical catalysis for the production of statin intermediates.
This paper references
10.1016/J.FBP.2010.01.003
Process considerations for the scale-up and implementation of biocatalysis
Pär Tufvesson (2010)
10.4103/2230-8210.113754
Safety of statins
D. Maji (2013)
Truppo, Biocatalysis in the Pharmaceutical Industry: The Need for Speed, ACS Med
M D. (2017)
10.1002/CHIN.199826324
Design by Directed Evolution.
F. Arnold (1998)
Chemoenzymatic Methods for the Synthesis of Statins and Statin Intermediates
W.Greenberg (2008)
10.1016/J.BEJ.2008.04.002
Kinetic modelling of aldolase-catalyzed addition between dihydroxyacetone phosphate and (S)-alaninal
Trinitat Suau (2008)
Process for the preparation of epoxide intermediates for pharmaceutical compounds such as statins
E. Mundorff (2007)
10.1016/j.ymben.2014.05.012
Engineered, highly productive biosynthesis of artificial, lactonized statin side-chain building blocks: The hidden potential of Escherichia coli unleashed.
Tadeja Vajdič (2014)
10.1021/OP400040B
Optimization of a Crude Deoxyribose-5-phosphate Aldolase Lyzate-Catalyzed Process in Synthesis of Statin Intermediates
A. Ručigaj (2013)
10.1002/CHIN.199548047
Sequential Three- and Four-Substrate Aldol Reactions Catalyzed by Aldolases.
H. J. M. Gijsen (1995)
10.1002/CHIN.200516261
Chemoenzymatic Synthesis of Building Blocks for Statin Side Chains
M. Mueller (2005)
10.1016/J.TETLET.2004.01.110
Sequential aldol condensation catalyzed by DERA mutant Ser238Asp and a formal total synthesis of atorvastatin
Junjie Liu (2004)
10.1002/ANIE.200460852
Chemoenzymatic synthesis of building blocks for statin side chains.
M. Müller (2005)
10.1002/9783527629688.CH5
Synthesis of Sitagliptin, the Active Ingredient in Januvia® and Janumet®
Jaume Balsells (2010)
Statini u prevenciji i liječenju zloćudnih bolesti
Hrvoje Rimac (2015)
10.2174/138527210791111858
Historic Overview and Recent Advances in the Synthesis of Super-statins
Zdenko Časar (2010)
10.1002/9783527811908.CH7
Rhodium(I)-catalyzed reductive carbon-carbon bond formation.
Adam D. J. Calow (2019)
10.1007/s00253-013-5357-0
Chemical and enzymatic approaches to the synthesis of optically pure ethyl (R)-4-cyano-3-hydroxybutanoate
Zhong-Yu You (2013)
10.1016/J.TIBTECH.2006.04.002
Environmental biocatalysis: from remediation with enzymes to novel green processes.
M. Alcalde (2006)
E
D. Mink (2007)
10.1021/CS500511C
Versatile and Efficient Immobilization of 2-Deoxyribose-5-phosphate Aldolase (DERA) on Multiwalled Carbon Nanotubes
Fabiana Subrizi (2014)
10.1515/9783111576855-009
D
Saskia Bonjour (1824)
10.1002/9783527629688.CH6
The Development of Short, Efficient, Economic, and Sustainable Chemoenzymatic Processes for Statin Side Chains
Martin Schuermann (2010)
10.1016/J.CLINBIOCHEM.2007.03.016
Mevalonate pathway: a review of clinical and therapeutical implications.
I. Buhăescu (2007)
10.1039/B412490A
Enantioselective C-C bond synthesis catalysed by enzymes.
Joly Sukumaran (2005)
10.1128/AEM.01101-07
Sequential Aldol Condensation Catalyzed by Hyperthermophilic 2-Deoxy-d-Ribose-5-Phosphate Aldolase
H. Sakuraba (2007)
The Relationships between Cholesterol and Suicide: An Update, ISRN Psychiatry
D. De Berardis (2012)
10.1039/b803584a
E factors, green chemistry and catalysis: an odyssey.
R. Sheldon (2008)
10.1007/s00253-006-0422-6
Microbial aldolases as C–C bonding enzymes—unknown treasures and new developments
A. K. Samland (2006)
10.1038/srep42064
Enhancing the biocatalytic manufacture of the key intermediate of atorvastatin by focused directed evolution of halohydrin dehalogenase
Yu Luo (2017)
10.1515/9783111576855-012
G
G.V.T.V. Weerasooriya (1824)
10.1016/J.MOLCATB.2009.07.004
Biocatalytic synthesis of atorvastatin intermediates
J. Patel (2009)
10.1016/j.cbpa.2009.01.018
Biocatalysis in development of green pharmaceutical processes.
J. Tao (2009)
Mayo , De Novo Design of Bio - catalysts
R. Blomberg (2002)
Biocatalysis, in W
Q. Wu (2012)
10.1515/9783111576855-015
J
Seguin Hen (1824)
10.4172/2155-6148.1000251
Statins as Potentially Neuroprotective Agents: A Review
Anuradha Patel (2012)
10.1016/j.jbiotec.2013.07.008
Mathematical model for aldol addition catalyzed by two D-fructose-6-phosphate aldolases variants overexpressed in E. coli.
M. Sudar (2013)
10.1016/J.MOLCATB.2010.10.008
Improvement of aldehyde tolerance and sequential aldol condensation activity of deoxyriboaldolase via immobilization on interparticle pore type mesoporous silica
Takayuki Y. Nara (2011)
10.1097/00006199-195206000-00001
Introduction to the
J. D. Hostettler (1983)
10.1002/anie.201000826
Laboratory evolution of stereoselective enzymes: a prolific source of catalysts for asymmetric reactions.
M. Reetz (2011)
10.1002/CHIN.200026262
The Catalytic Asymmetric Aldol Reaction
T. Machajewski (2000)
10.1002/cbic.200700734
Catalytic Promiscuity of Halohydrin Dehalogenase and its Application in Enantioselective Epoxide Ring Opening
Ghannia Hasnaoui‐Dijoux (2008)
10.1007/s11883-014-0420-6
Primary Prevention of Cardiovascular Disease with Statins in the Elderly
Ž. Reiner (2014)
Hagelüken , Markets for the Catalyst Metals Platinum , Palladium and Rhodium , Metall
R. Ballini (2006)
10.1126/SCIENCE.1059344
Structural Mechanism for Statin Inhibition of HMG-CoA Reductase
E. Istvan (2001)
10.5402/2012/387901
The Relationships between Cholesterol and Suicide: An Update
D. De Berardis (2012)
10.1002/JCTB.5956
2-Deoxyribose-5-phosphate aldolase from Thermotoga maritima in the synthesis of a statin side-chain precursor: characterization, modeling and optimization
A. Švarc (2019)
Markets for the catalyst metals platinum, palladium and rhodium
C. Hagelüken (2006)
Vrsalović-Presečki, Modeling as a Tool of Enzyme Reaction Engineering for Enzyme Reactor
Đ. Vasić-Rački (2011)
10.1515/9783111697888-007
E
Adam S. Opalski (1824)
10.1351/pac199466010117
Biochemical engineering in biotechnology (Technical Report)
M. Moo-Young (1994)
10.1002/9781118309872.CH1
Transition Metal Catalysis in the Pharmaceutical Industry
C. Busacca (2012)
The Development of Short, Efficient, Economic, and Sustainable Chemoenzymatic Processes for Statin Side Chains, in P
M. Schürmann (2010)
10.1002/(SICI)1521-3773(20000417)39:8<1352::AID-ANIE1352>3.0.CO;2-J
The Catalytic Asymmetric Aldol Reaction.
Machajewski (2000)
10.1007/s00253-016-7750-y
Recent advances on halohydrin dehalogenases—from enzyme identification to novel biocatalytic applications
A. Schallmey (2016)
10.1073/PNAS.0307563101
Development of an efficient, scalable, aldolase-catalyzed process for enantioselective synthesis of statin intermediates.
W. A. Greenberg (2004)
10.1146/annurev-biochem-062917-012034
Directed Evolution of Protein Catalysts.
Cathleen Zeymer (2018)
10.1002/9783527677122.CH16
Pharmaceutical Intermediates by Biocatalysis: From Fundamental Science to Industrial Applications
Ramesh N. Patel (2016)
10.2183/pjab.86.484
A historical perspective on the discovery of statins
A. Endo (2010)
10.1371/journal.pone.0062250
A Highly Productive, Whole-Cell DERA Chemoenzymatic Process for Production of Key Lactonized Side-Chain Intermediates in Statin Synthesis
Matej Ošlaj (2013)
10.4155/PBP.13.14
Recent advances in biocatalyst development in the pharmaceutical industry
M. M. Zhang (2013)
10.1007/s00253-011-3414-0
Modelling as a tool of enzyme reaction engineering for enzyme reactor development
D. Vasić-Rački (2011)
10.1039/C5CY00537J
Efficient synthesis of a statin precursor in high space-time yield by a new aldehyde-tolerant aldolase identified from Lactobacillus brevis
Xue-Cheng Jiao (2015)
10.1038/35051719
Improving enzymes by using them in organic solvents
Alexander M. Klibanov (2001)
10.1007/s00253-015-6390-y
Principles, techniques, and applications of biocatalyst immobilization for industrial application
Ismail Eş (2015)
10.1016/S0958-1669(03)00099-5
Directed evolution of industrial enzymes: an update.
J. R. Cherry (2003)
10.3390/CATAL8060238
Industrial Applications of Enzymes: Recent Advances, Techniques, and Outlooks
Jordan M Chapman (2018)
10.1016/j.cbpa.2013.02.012
De novo enzymes by computational design.
Hajo Kries (2013)
Gruber-Khadjawi, Biocatalytic Methods for C−C Bond Formation
M. K. Fesko (2013)
10.1039/C0GC00595A
Enzyme-mediated oxidations for the chemist
F. Hollmann (2011)
10.1021/acscentsci.6b00272
Iron Catalysis in Organic Synthesis: A Critical Assessment of What It Takes To Make This Base Metal a Multitasking Champion
A. Fürstner (2016)
10.1016/J.CBPA.2005.02.007
Advances in biocatalytic synthesis of pharmaceutical intermediates.
S. Panke (2005)
10.1039/C6CY01085G
A green-by-design system for efficient bio-oxidation of an unnatural hexapyranose into chiral lactone for building statin side-chains
Xue-Cheng Jiao (2016)
Protection for the Thiol Group, in P
P. Wuts (2006)
10.1515/9783111548050-035
Z
Axel M. Gressner (2012)
10.2478/acph-2013-0022
Drug interactions with statins
A. Čaušević-Ramoševac (2013)
10.1016/J.TIBTECH.2006.12.005
Biocatalysis for pharmaceutical intermediates: the future is now.
D. Pollard (2007)
10.1007/s10295-012-1213-y
Characterization and application of a newly synthesized 2-deoxyribose-5-phosphate aldolase
Zhong-Yu You (2012)
10.1021/CR0200769
Protection (and deprotection) of functional groups in organic synthesis by heterogeneous catalysis.
G. Sartori (2004)
10.1002/CHIR.20494
The discovery of biological enantioselectivity: Louis Pasteur and the fermentation of tartaric acid, 1857--a review and analysis 150 yr later.
J. Gal (2008)
10.1002/CHIN.201339260
Biocatalytic Methods for C—C Bond Formation
Kateryna Fesko (2013)
10.1038/nrd2961
Lessons from 60 years of pharmaceutical innovation
B. Munos (2009)
10.1002/CHIN.200736266
Enzyme Immobilization: The Quest for Optimum Performance
R. Sheldon (2007)
10.1016/j.biotechadv.2018.06.002
Integrating enzyme immobilization and protein engineering: An alternative path for the development of novel and improved industrial biocatalysts.
C. Bernal (2018)
10.1007/s00253-016-7493-9
Biochemical and biocatalytic characterization of 17 novel halohydrin dehalogenases
J. Koopmeiners (2016)
10.1016/J.PROCBIO.2017.08.001
An industrially applied biocatalyst: 2-Deoxy-d-ribose-5- phosphate aldolase
Hui Fei (2017)
Effect of the Principal Nutrients on Simvastatin Production by Wild Strain Aspergillus terreus 20 in Submerged Fermentation
S. M. Nasmetova (2015)
10.1016/J.CEJ.2014.07.124
Kinetic modeling of a crude DERA lysate-catalyzed process in synthesis of statin intermediates
Aleš Ručigaj (2015)
10.1042/BST20060291
Enantioselective formation and ring-opening of epoxides catalysed by halohydrin dehalogenases.
D. Janssen (2006)
10.1038/nature11117
Engineering the third wave of biocatalysis
U. Bornscheuer (2012)
10.1002/BIOT.200600020
Directed evolution of an industrial biocatalyst: 2-deoxy-D-ribose 5-phosphate aldolase.
S. Jennewein (2006)
A process for the preparation of 2- (6-substituted 1,3-dioxane-4-yl) acetic acid derivatives
D. Mink (2001)



Semantic Scholar Logo Some data provided by SemanticScholar